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 Introduction 
 To ensure the meticulous transmission of genetic information, 
there exists a series of checkpoints that are activated when DNA 
damage is detected. At the apex of the signaling cascade initi-
ated after the detection of DNA double-strand breaks is the 
serine/threonine protein kinase ataxia telangiectasia mutated 
(ATM;  Abraham, 2001 ). ATM has been shown to phosphorylate 
a broad range of substrates upon activation, including NBS1, 
BRCA1, and Chk2. ATM patients show symptoms including 
neural degeneration, immunodefi ciency, growth retardation, pre-
mature aging, cancer predisposition, and severe sensitivity to 
ionizing radiation (IR;  Shiloh, 2003 ), with ATM-defi cient mice 
displaying many of these phenotypes ( Xu and Baltimore, 1996; 
Xu et al., 1996 ). Thus, understanding the ATM signaling cas-
cade has been pivotal to discovering the mechanisms underly-
ing genomic instability and tumorigenesis. Recently, 53BP1 and 
MDC1 have been recognized as critical upstream mediators in 
the cellular response to double-strand breaks, although the ex-
tent and nature of their interaction is not known. 
 53BP1 has been suggested to be the mammalian ortho-
logue of scRad9/spCrb2, a protein critical for DNA damage 
response (DDR) in yeast. Like many proteins of the DDR path-
ways, 53BP1 contains tandem BRCA1 C-terminal (BRCT) do-
mains. In addition, 53BP1 contains a tudor domain that binds 
methylated K79 of histone H3 or K20 of histone H4 ( Huyen et al., 
2004 ). 53BP1 is phosphorylated after IR in an ATM-dependent 
fashion and localizes to IR-induced foci ( Schultz et al., 2000; 
Anderson et al., 2001 ;  Rappold et al., 2001 ). Furthermore, mod-
erate checkpoint defects have been reported in cells depleted of 
53BP1 ( Fernandez-Capetillo et al., 2002 ;  Wang et al., 2002 ). 
Analysis of 53BP1 knockout (KO) mice confi rmed an impor-
tant role for 53BP1 in genomic stability ( Morales et al., 2003 ; 
 Ward et al., 2003 ), with null mice recapitulating some of the 
ATM-defi cient phenotypes, although they were less severe (no-
tably growth retardation, mild checkpoint defect, genomic in-
stability, and mild tumor incidence). These moderate phenotypes 
challenge the notion that 53BP1 is the only orthologue of the 
original scRad9. 
 Subsequently, MDC1 was identifi ed and described by sev-
eral groups as being a critical mediator of DDR ( Stucki and 
Jackson, 2004 ). MDC1 contains tandem BRCT domains as 
well as a forkhead-associated domain and a repeat region, which 
also mediate protein interactions. Through its BRCT domains, 
MDC1 binds   H2AX and recruits activated ATM to the sites of 
The importance of the DNA damage response (DDR) pathway in development, genomic stability, and tu-mor suppression is well recognized. Although 53BP1 
and MDC1 have been recently identifi ed as critical up-
stream mediators in the cellular response to DNA double-
strand breaks, their relative hierarchy in the ataxia 
telangiectasia mutated (ATM) signaling cascade remains 
controversial. To investigate the divergent and potentially 
overlapping functions of MDC1 and 53BP1 in the ATM 
response pathway, we generated mice defi cient for both 
genes. Unexpectedly, the loss of both MDC1 and 53BP1 
neither signifi cantly increases the severity of defects in 
DDR nor increases tumor incidence compared with the 
loss of MDC1 alone. We additionally show that MDC1 
regulates 53BP1 foci formation and phosphorylation in 
response to DNA damage. These results suggest that 
MDC1 functions as an upstream regulator of 53BP1 in the 
DDR pathway and in tumor suppression.
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DNA damage, thus amplifying DNA damage signals ( Stucki 
et al., 2005; Lou et al., 2006 ). siRNA against MDC1 were used 
to demonstrate MDC1 ’ s role in G2/M checkpoint response, 
IR- induced foci formation, and Chk2 signaling ( Stucki and 
Jackson, 2004 ). A role of MDC1 in DNA repair has also been 
demonstrated ( Lou et al., 2004 ;  Zhang et al., 2005 ). However, it 
was not until MDC1 KO mice were generated that the impor-
tance of MDC1 ’ s function in ATM signaling and genomic sta-
bility became apparent ( Lou et al., 2006 ). MDC1-null mice 
displayed many of the phenotypes associated with ATM defi -
ciency: growth retardation, IR sensitivity, male infertility, gross 
genomic instability, and S-phase and G2/M checkpoint defects. 
Although it remains to be determined whether MDC1 has tumor 
suppressor functions in vivo, so far the phenotypes observed 
in MDC1   /   mice are milder than those of ATM   /   mice, sug-
gesting that MDC1, like 53BP1, only regulates a subset of 
ATM signaling. 
 The data regarding the interactions between MDC1 and 
53BP1 in the ATM signaling cascade have often been confl ict-
ing; although both 53BP1 and MDC1 are required for correct 
and robust DDR, there are some differences between the two 
proteins. Notably, 53BP1 does not seem to play a major role in 
checkpoint activation but is crucial in a subset of DNA repair 
functions, especially class-switch recombination (CSR;  Manis 
et al., 2004 ;  Ward et al., 2004 ). In contrast, MDC1 seems to 
have major role in checkpoint activation but a moderate role in 
DNA repair. Thus, it appears that MDC1 and 53BP1 may regu-
late separate branches of the DDR downstream of ATM. To 
clarify these points, we generated mice defi cient of both MDC1 
and 53BP1 and investigated how the loss of both MDC1 and 
53BP1 affects DDR and tumorigenesis. 
 Results and discussion 
 MDC1/53BP1 defi ciency and 
radiosensitivity 
 One of the hallmarks of defective DDR is hypersensitivity to 
IR. ATM-, MDC1-, and 53BP1-defi cient mice have been shown 
to be hypersensitive to IR ( Xu and Baltimore, 1996; Ward et 
al., 2003; Lou et al., 2006 ). Mice defi cient for both MDC1 and 
53BP1 (double  KO  [DKO]) demonstrated similar overall 
levels of morbidity to the MDC1   /   and 53BP1   /   mice 12 d 
after 7 Gy whole body irradiation ( Fig. 1 A ), all of whose sur-
vival were signifi cantly lower than the survival of wild-type 
(WT) mice (53BP1   /   , P = 0.0164; MDC1   /   , P = 0.0494; 
DKO, P = 0.0455). DKO survival after IR was distinct from 
that of the single KOs, as the DKO onset of morbidity was ear-
lier than that of the single KOs, although this did not corre-
spond with a signifi cant decrease in survival (P = 0.4672 for 
MDC1 KO and P = 0.7968 for 53BP1 KO). Correlating with 
the whole body IR results, mouse embryonic fi broblasts (MEFs) 
from MDC1   /   or 53BP1   /   mice show sensitivity to IR 
( Fig. 1 B ) as previously reported ( Ward et al., 2003; Lou et al., 
2006 ). MEFs from DKO mice are only slightly more sensi-
tive to IR than those from MDC1   /   or 53BP1   /   mice, al-
though not statistically more so (P = 0.668 for MDC1   /   and 
P = 0.439 for 53BP1   /   ). 
 Figure 1.  Radiosensitivity of DKO mice and MEFs. (A) Kaplan-Meier sur-
vival curve of WT ( n = 9), 53BP1   /   ( n = 8), MDC1   /   ( n = 10), and DKO 
( n = 8) mice after 7 Gy of whole body IR. (B) Survival of WT, 53BP1   /   , 
MDC1   /   , and DKO MEFs 5 d after 0, 1, and 2 Gy IR as determined by 
Trypan blue exclusion. Error bars represent SEM from two independent ex-
periments. (C) Survival of WT, 53BP1   /   , MDC1   /   , and DKO MEFs 48 h 
after continuous treatment with the indicated amounts of MMC. Error bars 
represent SEM from four independent experiments. 
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 Figure 2.  Genomic instability in 53BP1   /   , MDC1   /   , and DKO MEFs. Mitotic spreads were produced as described in Materials and methods. (A) The 
percentage of mitotic spreads with spontaneous chromosomal abnormalities was determined by light microscopy. The asterisk denotes a signifi cant differ-
ence from WT (53BP1   /   compared with WT, P = 0.00019; MDC1   /   compared with WT, P = 3.35  × 10   6 ; DKO compared with WT, P = 1.01  × 10   11 ). 
(B) Representative pictures of chromosomal aberrations from DKO MEFs. Different aberrations are indicated by colored arrows. (C) Percentage of metaphase 
spreads with the indicated number of DNA breaks from unirradiated or irradiated MEFs. 100 metaphase spreads/genotype were evaluated. Bar, 10  μ M. 
JCB • VOLUME 181 • NUMBER 5 • 2008 730 
 To further confi rm our IR data, we chose to test the sen-
sitivity of these cell lines to the DNA cross-linking agent 
mitomycin C (MMC). As shown in  Fig. 1 C , 53BP1 KO MEFs 
showed a mild, insignifi cant resistance to MMC when com-
pared with WT (P = 0.167). MMC-induced DNA damage is be-
lieved to be mainly repaired by the homologous recombination 
(HR) pathway ( Brugmans et al., 2007 ), and loss of 53BP1 has 
been shown to enhance HR as a result of its suppressive role in 
HR ( Xie et al., 2007 ), which could contribute to this mild resis-
tance to MMC in 53BP1   /   cells. Inversely, the loss of MDC1, 
which has been reported to be involved in HR pathways ( Zhang 
et al., 2005; Xie et al., 2007 ), resulted in mild decreased sur-
vival in comparison to WT (P = 0.071). However, the DKO line 
displayed a signifi cantly higher sensitivity to MMC than WT 
and 53BP1 lines (P = 0.0031 and P  < 0.0001, respectively) but 
was not signifi cantly more sensitive to MMC than the MDC1 
KO line (P = 0.2267). This result suggests that although MDC1 
and 53BP1 may have distinct repair functions, the loss of 
MDC1 is a dominant effect in the context of DKO. 
 MDC1/53BP1 defi ciency and 
genomic instability 
 As MEFs from both MDC1   /   and 53BP1   /   mice have been 
shown to have higher rates of genomic instability ( Ward et al., 
2003; Lou et al., 2006 ), we next examined how the loss of both 
MDC1 and 53BP1 affects chromosome stability before and af-
ter IR. Mitotic spreads prepared from single and DKO passage 
1 MEFs were examined by light microscopy. Although unirradi-
ated WT MEFs had relatively few spontaneous chromosomal 
aberrations (14% of MEFs examined), including chromatid 
breaks, chromosome fusions, and fragments from chromosome 
breaks, 53BP1   /   and MDC1   /   MEFs had a signifi cantly higher 
incidence with 40% and 60% of spreads containing chromo-
some aberrations, respectively (P = 0.00019 and P = 3.35  × 
10   6 , respectively;  Fig. 2 A ). The MEFs from DKO mice dis-
played slightly more chromosome aberrations than those of 
MDC1   /   MEFs (70%;  Fig. 2, A and B ), which is not consid-
ered a statistically signifi cant increase (P = 0.8) but is highly 
signifi cant when compared with spontaneous breaks in WT and 
53BP1 KO cells (P = 1.01  × 10   11 for WT and P = 0.00016 for 
53BP1 KO). 
 We next examined DNA breaks caused by IR. Cells were 
treated with 1 Gy IR and were allowed to recover for 1 h, and 
spreads were made and examined for chromosome aberrations. 
As shown in  Fig. 2 C , WT MEFs had zero to four breaks per 
spread, with zero being the highest frequency at 40% followed 
by one-break frequencies of 38%. 53BP1   /   cells had between 
zero and eight breaks per spread, with two and then one break 
per spread being the most prevalent. MDC1   /   MEFs again 
appear more sensitive to chromosomal aberrations than WT 
or 53BP1   /   and had  > 90% of spreads containing two or more 
breaks. The DKOs recapitulate the MDC1   /   phenotype more 
closely with a larger proportion of spreads containing two or 
more chromosomal abnormalities after IR. The data shown in 
 Figs. 1 and 2 relating to IR sensitivity, DNA repair, and genomic 
stability suggest that the loss of MDC1 contributes to most of 
the phenotypes observed in DKO mice and cells. 
 MDC1/53BP1 defi ciency, development, 
and tumorigenesis 
 We also examined how the loss of 53BP1 and MDC1 affects 
development and tumorigenesis. Although ATM   /   mice are in-
fertile ( Xu et al., 1996 ), 53BP1   /   mice show normal fertility ( Ward 
et al., 2003 ), as MDC1   /   mice show an intermediate pheno-
type with male MDC1   /   mice being infertile and females 
showing reduced fertility ( Lou et al., 2006 ). The DKO mice 
showed the same fertility phenotype as MDC1   /   mice (un-
published data). 
 We next evaluated immunological phenotypes. ATM   /   
mice show defects in both CSR and T cell development ( Xu and 
Baltimore, 1996; Xu et al., 1996 ). Although 53BP1   /   mice show 
a severe defect in CSR ( Manis et al., 2004 ;  Ward et al., 2004 ) and 
a decreased number of mature T cells, overall T cell development 
appears to be intact ( Morales et al., 2003 ;  Ward et al., 2003 ). 
Similarly, MDC1   /   mice show a moderate defect in CSR and no 
apparent abnormalities in T cell development ( Lou et al., 2006 ). 
To examine whether the loss of both MDC1 and 53BP1 would 
result in a defect in T cell development, we stained CD4 and CD8 
of lymphocytes isolated from the thymus of WT, MDC1   /   , 
53BP1   /   , and DKO mice. Like that of MDC1   /   and 53BP1   /   
mice, no obvious defect in T cell development was observed in 
DKO mice ( Fig. 3 A ). These results suggest that unlike ATM, 
MDC1 and 53BP1 are not essential for T cell development. 
 Finally, we examined spontaneous tumor incidence in 
WT, MDC1   /   , and DKO mice. 10.5% of WT mice developed 
tumors by the age of 21 mo, whereas 25% of MDC1   /   mice 
developed tumors (P = 0.0001;  Fig. 3 B ). The majority of tu-
mors from WT and MDC1   /   mice are lymphomas, which 
also metastasized to other organs, such as the lung, liver, and 
gastrointestinal tract ( Fig. 3, C and D ). These results are the 
fi rst to demonstrate that MDC1 acts as a tumor suppressor, 
suggesting that genomic instability caused by the loss of 
MDC1 does contribute to tumorigenesis. However, the loss of 
both 53BP1 and MDC1 only resulted in a mild increase in 
tumor incidence in comparison to the loss of MDC1 alone (P = 
0.356;  Fig. 3 B ). 
 53BP1 and MDC1 in the DNA damage 
signaling pathway 
 A previous study using siRNAs suggests that MDC1 and 53BP1 
work in parallel pathways to activate ATM ( Mochan et al., 2003 ). 
We used MEFs from MDC1   /   , 53BP1   /   , and DKO mice to 
verify this observation. In contrast to  Mochan et al. (2003 ), we 
found that neither the absence of MDC1 or 53BP1 alone signifi -
cantly affected the autophosphorylation at serine 1981 of ATM 
after IR ( Fig. 4 A and Fig. S1, A and B; available at http://www
.jcb.org/cgi/content/full/jcb.200801083/DC1) even at low doses 
of IR. Furthermore, there was no signifi cant decrease in ATM 
phosphorylation in the DKO cells ( Fig. 4 A and Fig. S1, A and B). 
Interestingly, there was some decrease in ATM phosphorylation 
at a later time point, supporting a possible role of MDC1 in main-
taining ATM phosphorylation ( Fig. 4 B ). However, the loss 
of both MDC1 and 53BP1 did not further decrease ATM 
phosphorylation. These results suggest that MDC1 and 53BP1 
are not critical for ATM activation. 
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MDC1 does not cause more severe checkpoint defects than the 
loss of MDC1 alone. 
 MDC1 regulates 53BP1 phosphorylation 
and localization at the sites of 
DNA damage 
 Our results with 53BP1/MDC1 DKO mice and cells suggest that 
MDC1 and 53BP1 likely function on the same molecular path-
way downstream of ATM. Confl icting results have been reported 
as to whether 53BP1 foci formation requires MDC1, possibly as 
a result of the different siRNA used and the extent of MDC1 
knockdown ( Goldberg et al., 2003 ;  Peng and Chen, 2003; Stewart 
et al., 2003 ;  Bekker-Jensen et al., 2005 ). We found that 53BP1 
failed to form foci in MDC1   /   cells in response to DNA dam-
age ( Fig. 5 A ). On the other hand, MDC1 foci formation is nor-
mal in 53BP1   /   cells. These results suggest that MDC1 is an 
upstream regulator of 53BP1 localization after DNA damage. 
 Recent studies suggest that MDC1 might regulate the lo-
calization of DNA damage factors through the E3 ubiquitin li-
gase RNF8, which ubiquitinates H2AX and creates binding 
 We also examined how the loss of MDC1 and 53BP1 af-
fects downstream signals of the DDR. MDC1 and 53BP1 have 
previously been shown to regulate Chk1 and Chk2 phosphory-
lation ( Wang et al., 2002, 2003; Peng and Chen, 2003 ;  Stewart 
et al., 2003 ;  Lou et al., 2006 ). MDC1   /   and 53BP1   /   MEFs 
showed weak activation of Chk1 and Chk2. However, the loss 
of both MDC1 and 53BP1 did not further decrease Chk1 and Chk2 
phosphorylation ( Fig. 4, A and B ; and Fig. S1 B). Although we 
did observe a reproducible defect in Chk2 phosphorylation, the 
decreased level of Chk2 seen in MDC1 KO cells was observed 
in some, but not all, experiments. Finally, we examined check-
point activation in MDC1   /   , 53BP1   /   , and DKO MEFs. Both 
MDC1 and 53BP1 have been shown to regulate the G2/M 
checkpoint. As has been previously reported, the loss of MDC1 
resulted in a defective G2/M checkpoint, with more cells able to 
enter mitosis after IR than in WT cells ( Fig. 4 C ). Similarly, the 
loss of 53BP1 also resulted in some inappropriate progression 
into mitosis. However, in DKO cells, the observed G2/M check-
point defect is comparable to that seen in MDC1-null cells 
( Fig. 4 C ). These results suggest that the loss of both 53BP1 and 
 Figure 3.  T cell development, tumor incidence, and spectrum in WT, MDC1   /   , and DKO mice.  (A) Lymphocytes from WT, MDC1   /   , 53BP1   /   , and 
DKO mice. Numbers in each quadrant indicate percentage of the total population. (B and C) Spontaneous tumor incidence and spectrum in WT ( n = 19), 
MDC1   /   ( n = 20), and DKO ( n = 27) mice for up to 21 mo were determined. The asterisk denotes signifi cant difference from WT (tumor incidence in 
MDC1   /   mice compared with WT mice, P = 7.6  × 10   6 ; incidence in DKO mice compared with WT, P = 1.26  × 10   9 ). (D) Representative pictures of 
lymphoma and lung cancer from MDC1   /   and DKO mice. 
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tion, whereas MDC1 foci formation remained intact ( Fig. 5 B ). 
On the other hand, RNF8 foci formation is dependent on MDC1 
( Fig. 5 C ), suggesting the existence of an MDC1 – RNF8 – 53BP1 
pathway for the accumulation of 53BP1 at or near the sites of 
DNA damage. 
sites for downstream factors, such as BRCA1 and 53BP1 
( Huen et al., 2007 ;  Kolas et al., 2007 ;  Mailand et al., 2007 ; 
 Wang and Elledge, 2007 ). To confi rm these studies, we gener-
ated RNF8   /   mice and isolated MEFs from RNF8   /   mice. 
Loss of RNF8 resulted in the failure of 53BP1 foci forma-
 Figure 4.  DKO MEFs do not have more severe defects in ATM activation and G2/M checkpoint activation. (A and B) ATM, Chk1, and Chk2 activation in 
wild-type (WT), MDC1   /   , and double knockout (DKO or MDC1/53BP1   /   ) MEFs. MEFs of the indicated genotypes were irradiated at the indicated doses 
and harvested 1 h later (A) or irradiated (2 Gy) and harvested at different time points (B). Cell extracts were then blotted with the indicated antibodies. 
(C) MEFs were left untreated or irradiated (2 Gy). 1 h later, cells were stained for antiphospho-H3 antibodies, and mitotic populations were determined 
by FACS. Error bars represent SEM. 
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 Figure 5.  MDC1 regulates 53BP1 foci formation and phosphorylation. (A – C) MEFs of the indicated genotypes were irradiated (10 Gy), and foci forma-
tion of MDC1, 53BP1, RNF8, and   H2AX was determined by immunofl uorescence. (D) MDC1 +/+ and MDC1   /   MEF cells were irradiated (2 Gy), and, 
1 h later, 53BP1 was immunoprecipitated and blotted with the indicated antibodies. (E) Proposed model of the regulation of 53BP1 phosphorylation and 
localization by MDC1. Bars, 10  μ M. 
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 Our studies on organism development and tumorigenesis 
further highlight the fact that genomic instability is a driving 
force of tumorigenesis, supporting the data that many DDR fac-
tors function as potent tumor suppressors. 53BP1 has been show 
to function as a tumor suppressor in mice ( Ward et al., 2003; 
Morales et al., 2006 ), whereas our data are the fi rst to suggest a 
role for MDC1 in tumor suppression. A recent study showed the 
loss of MDC1 expression in breast and lung cancer samples, 
supporting a potential role of MDC1 in tumor suppression in 
humans ( Bartkova et al., 2007 ). However, MDC1 mutations have 
not yet been identifi ed in human cancer samples. We did not 
fi nd that loss of both MDC1 and 53BP1 signifi cantly increased 
tumor incidence compared with MDC1 KO mice. Interestingly, 
the loss of MDC1 and 53BP1 is mostly mutually exclusive in 
human cancer samples ( Bartkova et al., 2007 ). These results in-
dicate that the loss of either MDC1 or 53BP1 is suffi cient for 
tumorigenesis, and the loss of both does not provide an overt 
additional advantage for tumor formation. Collectively, our studies 
clearly establish MDC1 as a tumor suppressor and an upstream 
regulator of 53BP1 in the DDR pathway. 
 Materials and methods 
 Generation of 53BP1/MDC1 DKO mice, RNF8-defi cient mice, and MEFs 
 MDC1 +/   female mice ( Lou et al., 2006 ) were bred with 53BP1   /   male 
mice ( Ward et al., 2003 ) to generate 53BP1 +/   MDC1 +/   offspring. Dou-
ble heterozygous females were then bred back to 53BP1   /   males to gen-
erate 53BP1   /   MDC1 +/   offspring, which were used for all subsequent 
breeding. Mice were observed daily for signs of poor health, and mori-
bund mice were killed and screened for tumors in accordance with Mayo 
Foundation Institutional Animal Care and Use Committee guidelines. 
 For the generation of RNF8-defi cient mice, two embryonic stem cell 
lines, RRR260 and PT238, were purchased from Bay Genomics. In the 
RRR260 embryonic stem cell line, the  RNF8 gene was disrupted by a neo 
gene selection cassette inserted between transcripted exon 4 to exon 5 of 
 RNF8 . In the PT238 cell line, a neo cassette was inserted between tran-
scripted exon 5 to exon 6. The exact insertion sites were mapped by geno-
mic PCR and DNA sequencing. Both embryonic stem cell lines were 
injected into C57BL/6 blastocysts to generate two independent chimeric 
mouse lines. The chimeric mice were then crossed back with C57BL/6 
mice to obtain RNF8 +/   mice, which were used for subsequent breeding to 
generate two independent RNF8   /   mice lines. Both RNF8   /   mice lines 
show identical phenotypes. All MEFs were generated from embryonic day 
13.5 or 14.5 embryos using standard procedures. 
 Metaphase spreads 
 Passage 1 MEFs were left unirradiated or were treated with 1 Gy and then 
incubated with 50 ng ml   1 colcemid for 3 – 4 h. Cells were collected, 
washed with PBS, resuspended in 75 mM KCl, and incubated at room tem-
perature for 15 min. Cells were fi xed in Carnoy ’ s solution (75% methanol 
and 25% acetic acid), and 15- μ l aliquots were dropped onto slides and 
stained with 5% Giemsa solution. Metaphase spreads were observed us-
ing a microscope (Eclipse 80i; Nikon) with a 40 × NA 1.3 oil objective 
lens at room temperature. Spreads were photographed and analyzed us-
ing a camera (Spot 2 Megasample; Diagnostic Instruments, Inc.) and Spot 
software 4.6 (Diagnostic Instruments, Inc.). 
 Immunofl uorescence 
 Cells were washed with PBS, incubated in 3% PFA for 12 min, and perme-
abilized in 0.5% Triton X-100 solution for 5 min at room temperature. 
Samples were blocked with 5% goat serum and incubated with primary 
antibody for 60 min. Samples were washed and incubated with secondary 
antibody (FITC and rhodamine labeled) for 60 min. Cells were then stained 
with DAPI to visualize nuclear DNA. The coverslips were mounted onto 
glass slides with antifade solution and visualized using an Eclipse 80i 
fl uorescence microscope with a 60 × NA 1.3 oil objective lens at room 
temperature. Spreads were photographed and analyzed using a Spot 2 
Megasample camera and Photoshop software (Adobe). 
 We further investigated whether MDC1 regulates 53BP1 
phosphorylation. 53BP1 is phosphorylated at S25/29 by ATM 
after DNA damage, and the phosphorylation of S25 has been 
shown to be important for the binding of Pax transactivation 
domain – interacting protein and proper DDR ( Munoz et al., 2007 ). 
As shown in  Fig. 5 D , 53BP1 phosphorylation at S25/29 is de-
fective in MDC1   /   cells, suggesting that MDC1 also regulates 
53BP1 phosphorylation after DNA damage. Collectively, our 
results suggest that MDC1 and 53BP1 act in the same molecu-
lar pathway of the DDR, and MDC1 is an upstream regulator of 
53BP1 by regulating 53BP1 phosphorylation and foci forma-
tion after DNA damage. 
 MDC1 and 53BP1 are two important mediator proteins of 
the DDR pathway. Our observations indicate that the phenotypes 
of MDC1   /   and DKO mice are substantially milder than that of 
ATM   /   mice, suggesting that it is unlikely that MDC1 and 
53BP1 are critical for ATM activation. Concurrently, our studies 
of DDR (radiosensitivity, DNA repair, and genomic stability) in-
dicate that the phenotypes of DKO mice and cells mostly resem-
ble those of MDC1 KO mice; this is in contrast to  scid /Rad54   /   
mice that showed a drastic increase in radiosensitivity compared 
with  scid or Rad54   /   mice ( Essers et al., 2000 ). Although a role 
in nonhomologous end joining and HR by 53BP1 and MDC1, 
respectively, has been suggested ( Xie et al., 2007 ), it is possible 
that 53BP1 and MDC1 only play a supporting role in these pro-
cesses, which were not obvious in our in vivo studies. 
 We have shown that MDC1 regulates 53BP1 localization to 
the sites of DNA damage and 53BP1 phosphorylation at S25/29, 
which is necessary for the correct phosphorylation of both Chk2 
and BRCA1 and subsequent checkpoint activation. Therefore, 
MDC1 might regulate these signaling events partially through 
its ability to control 53BP1 phosphorylation. Using MEFs from 
MDC1   /   and RNF8   /   mice, we show that 53BP1 localization 
to the sites of DNA damage requires RNF8, which, in turn, re-
quires MDC1. These results support several recent studies dem-
onstrating that MDC1 recruits RNF8 to the sites of DNA damage 
and RNF8, in turn, ubiquitinates H2AX, H2A, and probably other 
substrates at the sites of DNA breaks ( Huen et al., 2007 ;  Kolas 
et al., 2007 ;  Mailand et al., 2007 ;  Wang and Elledge, 2007 ). 
Ubiquitinated H2AX, H2A, or other RNF8 substrates would then 
recruit BRCA1 and 53BP1. BRCA1 is proposed to bind ubiq-
uitinated RNF8 substrates indirectly through a mediator protein, 
Rap80, which has an ubiquitin-binding domain ( Kim et al., 2007 ; 
 Sobhian et al., 2007 ;  Wang et al., 2007 ). However, Rap80 is not 
required for 53BP1 foci formation, suggesting that an unidenti-
fi ed factor mediates the binding of ubiquitinated protein and 
53BP1. Therefore, we propose an H2AX – MDC1 – RNF8 path-
way, which is distinct from methylated H3/H4 that also regulates 
53BP1 foci formation ( Fig. 5 E ). It is not clear why cells use two 
different mechanisms to regulate the localization of 53BP1 and 
whether these two mechanisms relate to each other. The fact that 
53BP1 but not MDC1 is essential for CSR and that 53BP1   /   
cells respond differently from MDC1   /   cells to MMC suggest 
that 53BP1 does have functions independent of MDC1. It is 
possible that the mode of 53BP1 recruitment is specifi c to the 
functions of 53BP1. These issues need to be further clarifi ed 
in the future. 
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 Western blotting 
 Cell lysates were prepared and Western blots were performed using stan-
dard protocols. Phospho-ATM antibodies were obtained from Rockland, 
and Chk1 and phospho-Chk1 antibodies were purchased from Cell Signal-
ing Technology. Anti – mouse ATM antibodies were generously provided by 
Y. Shiloh (Tel Aviv University, Tel Aviv, Israel). 
 The G2/M checkpoint assay 
 Cells were irradiated (2 Gy) and were harvested 1 h later. Cells were then 
fi xed and stained with antiphospho-H3 antibodies (Cell Signaling Technology). 
Mitotic population (mitotic index) was determined by FACS analysis. 
 Online supplemental material 
 Fig. S1 shows that DKO MEFs do not have more severe defects in the ATM-
 dependent DNA damage signaling pathway. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.200801083/DC1. 
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